<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1592">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05140434</url>
  </required_header>
  <id_info>
    <org_study_id>2021/0054</org_study_id>
    <nct_id>NCT05140434</nct_id>
  </id_info>
  <brief_title>Evaluation of the Benefit of Exercise Testing for the Diagnosis of Obstruction in the Coronary Arteries of the Heart</brief_title>
  <acronym>DP-Cor-1</acronym>
  <official_title>Evaluation of the Predictive Power of Double-product Increase Measured During an Exercise Test for the Prediction of Coronary Stenosis as Diagnosed by Cardiac CT Scan or Coronary Angiography.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Sud Francilien</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Sud Francilien</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether exercise testing can detect an obstruction&#xD;
      in a coronary artery, and, thereby, can avoid performing a coronary imaging in some cases.&#xD;
&#xD;
      Patients with a suspicion of coronary artery disease perform an exercise test on an exercise&#xD;
      bike with increasing load. EKG, blood pressure, and other parameters are monitored. Patients&#xD;
      benefit also of either a cardiac CT scan or a coronary angiography to establish whether they&#xD;
      really have coronary obstruction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Double product DP (product of systolic blood pressure and heart rate) is directly related to&#xD;
      the myocardial oxygen consumption (MVO2). Since O2 extraction by the myocyte in maximal at&#xD;
      rest, only an increase in coronary blood flow can increase MVO2 during exercise. Therefore,&#xD;
      if a coronary stenosis limits the maximal coronary flow, it will limit MVO2 and DP at&#xD;
      exercise.&#xD;
&#xD;
      Patients with both an exercise test and a coronary artery imaging (cardiac CT or coronary&#xD;
      angiography) within 3 months, are included. DP increase (DP max/DP at rest) is measured&#xD;
      during a maximal, symptom-limited exercise on a cycloergometer. DP at rest is measured either&#xD;
      before the exercise test, at the end of the recovery period or during a visit to the&#xD;
      cardiologist in the 2 months of the test, whichever is the smallest.&#xD;
&#xD;
      The predictive power to detect a significant coronary artery stenosis is assessed by&#xD;
      computing a Receiving Operating Characteristic (ROC) curve, its area under the curve,&#xD;
      sensitivity, specificity, and decision thresholds.&#xD;
&#xD;
      Number expected: 100-120 Subgroup of interest: women Time period of data collection: 1/1/2019&#xD;
      to 12/31/2022&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Area Under the ROC curve</measure>
    <time_frame>at 3 months</time_frame>
    <description>AUC of the ROC curve defined by DP increase and significant coronary artery stenosis or not</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Younden threshold</measure>
    <time_frame>at 3 months</time_frame>
    <description>Maximalization of the difference between sensitivity and 1-specificity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ROC for women</measure>
    <time_frame>at 3 months</time_frame>
    <description>AUC for women</description>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Exercice test</intervention_name>
    <description>exercise test on an exercise bike with increasing load</description>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiac CT</intervention_name>
    <description>cardiac CT scan</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Out-patients attending Centre Hospitalier Sud Francilien's cardiology department.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Starting 1/1/2019&#xD;
&#xD;
          -  8 year-old patients or older&#xD;
&#xD;
          -  Patients with both exercise testing and either Cardiac CT or coronary angiography&#xD;
             within 3 months&#xD;
&#xD;
          -  Patients informed and not opposing to their participation to the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients unable to fully understand the information related to the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Olivier CHARANSONNEY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Sud Francilien</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier CHARANSONNEY, MD</last_name>
    <phone>0161697766</phone>
    <email>olivier.charansonney@chsf.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline TOURTE</last_name>
    <phone>0161693730</phone>
    <email>caroline.tourte@chsf.fr</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 19, 2021</study_first_submitted>
  <study_first_submitted_qc>November 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2021</study_first_posted>
  <last_update_submitted>November 19, 2021</last_update_submitted>
  <last_update_submitted_qc>November 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exercise testing</keyword>
  <keyword>coronary stenosis</keyword>
  <keyword>double product</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Coronary Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

